In Vitro Models of the Blood-Brain Barrier

Methods Mol Biol. 2022:2492:25-49. doi: 10.1007/978-1-0716-2289-6_2.

Abstract

Traditional in vitro models can replicate many essential features of drug transport/permeability across the blood-brain barrier (BBB) but are not entirely projecting in vivo central nervous system (CNS) uptake. Species differences fail to translate experimental therapeutics from the research laboratory to the clinic. Improved in vitro modeling of human BBB is vital for both CNS drug discovery and delivery. High-end human BBB models fabricated by microfluidic technologies offer some solutions to this problem. BBB's complex physiological microenvironment has been established by increasing device complexity in terms of multiple cells, dynamic conditions, and 3D designs. It is now possible to predict the therapeutic effects of a candidate drug and identify new druggable targets by studying multicellular interactions using the advanced in vitro BBB models. This chapter reviews the current as well as an ideal in vitro model of the BBB.

Keywords: Alternative; Artificial; Barrier; Cells; Cerebrovascular; Endothelium; Models; Shear stress; TEER; iPSC.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Biological Transport
  • Blood-Brain Barrier* / physiology
  • Central Nervous System Agents*
  • Humans
  • Microfluidics
  • Permeability

Substances

  • Central Nervous System Agents